Loading...
Amyloid blood biomarker detects Alzheimer's disease
Alzheimer's disease (AD) is currently incurable, but there is general agreement that a minimally invasive blood biomarker for screening in preclinical stages would be crucial for future therapy. Diagnostic tools for detection of AD are either invasive like cerebrospinal fluid (CSF) biomarkers o...
Na minha lista:
| Udgivet i: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5938617/ https://ncbi.nlm.nih.gov/pubmed/29626112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201708763 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|